Nigrovic has proposed a biphasic model of sJIA in which innate immune factors dominate the initial disease presentation, whereas adaptive immune components, such as a skewing of the CD4+ T cell population to favor Th17 over regulatory T cell development, contribute in those patients in whom chronic arthritis develops17. The gene discussed is CD4; the disease is systemic-onset juvenile idiopathic arthritis.